[go: up one dir, main page]

DK1054665T3 - Farmaceutisk præparat omfattende en kombination af metformin og fibrat og anvendelse deraf til fremstilling af medikamenter beregnet til at reducere hyperglykæmi - Google Patents

Farmaceutisk præparat omfattende en kombination af metformin og fibrat og anvendelse deraf til fremstilling af medikamenter beregnet til at reducere hyperglykæmi

Info

Publication number
DK1054665T3
DK1054665T3 DK99910169T DK99910169T DK1054665T3 DK 1054665 T3 DK1054665 T3 DK 1054665T3 DK 99910169 T DK99910169 T DK 99910169T DK 99910169 T DK99910169 T DK 99910169T DK 1054665 T3 DK1054665 T3 DK 1054665T3
Authority
DK
Denmark
Prior art keywords
fibrate
metformin
manufacture
combination
pharmaceutical composition
Prior art date
Application number
DK99910169T
Other languages
Danish (da)
English (en)
Inventor
Yves Bonhomme
Philippe Briet
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK1054665T3 publication Critical patent/DK1054665T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99910169T 1998-02-12 1999-01-30 Farmaceutisk præparat omfattende en kombination af metformin og fibrat og anvendelse deraf til fremstilling af medikamenter beregnet til at reducere hyperglykæmi DK1054665T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9801709A FR2774591B1 (fr) 1998-02-12 1998-02-12 Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
PCT/EP1999/000614 WO1999040904A2 (fr) 1998-02-12 1999-01-30 Composition pharmaceutique comprenant une combinaison de metformine et de fibrate, et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie

Publications (1)

Publication Number Publication Date
DK1054665T3 true DK1054665T3 (da) 2001-12-27

Family

ID=9522912

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99910169T DK1054665T3 (da) 1998-02-12 1999-01-30 Farmaceutisk præparat omfattende en kombination af metformin og fibrat og anvendelse deraf til fremstilling af medikamenter beregnet til at reducere hyperglykæmi

Country Status (27)

Country Link
US (1) US6372790B1 (fr)
EP (1) EP1054665B1 (fr)
JP (1) JP4767411B2 (fr)
KR (1) KR100567608B1 (fr)
CN (1) CN1151785C (fr)
AR (1) AR018286A1 (fr)
AT (1) ATE204754T1 (fr)
AU (1) AU746821B2 (fr)
BR (1) BRPI9907866B8 (fr)
CA (1) CA2320039C (fr)
CZ (1) CZ290101B6 (fr)
DE (1) DE69900249T2 (fr)
DK (1) DK1054665T3 (fr)
ES (1) ES2162517T3 (fr)
FR (1) FR2774591B1 (fr)
HU (1) HU224619B1 (fr)
ID (1) ID26254A (fr)
MY (1) MY118164A (fr)
NO (1) NO328314B1 (fr)
PL (1) PL196874B1 (fr)
PT (1) PT1054665E (fr)
RU (1) RU2207850C2 (fr)
SK (1) SK283212B6 (fr)
TW (1) TW518222B (fr)
UA (1) UA70315C2 (fr)
WO (1) WO1999040904A2 (fr)
ZA (1) ZA991077B (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2216335T3 (es) * 1997-12-08 2004-10-16 Bristol-Myers Squibb Company Nuevas sales de metformina y procedimiento.
US6982281B1 (en) 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
FR2796551B1 (fr) * 1999-07-23 2003-07-25 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
FR2796940B1 (fr) * 1999-07-26 2005-04-08 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
JP4879433B2 (ja) * 2000-01-13 2012-02-22 エミスフェアー・テクノロジーズ・インク 活性剤を送達するための化合物および組成物
US6531158B1 (en) * 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
JP4829411B2 (ja) * 2001-02-23 2011-12-07 キッセイ薬品工業株式会社 Ｃ型慢性肝炎治療剤
GB0119480D0 (en) 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
US8911781B2 (en) 2002-06-17 2014-12-16 Inventia Healthcare Private Limited Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides
EP1424070A1 (fr) * 2002-11-28 2004-06-02 Fournier Laboratories Ireland Limited Combinaison d'un agoniste de PPAR-alpha et de metformine pour la réduction du taux de triglycérides sériques
JP2006511525A (ja) 2002-12-13 2006-04-06 ヤゴテック アーゲー ナノ粒子状スピロノラクトン局所製剤
EP1595544A4 (fr) * 2003-02-07 2009-05-06 Ajinomoto Kk Remede contre le diabete
FR2851734B1 (fr) * 2003-02-28 2006-06-09 Galenix Innovations Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
RU2241449C1 (ru) * 2003-09-25 2004-12-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция для лечения диабета (варианты)
US8062664B2 (en) * 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
RU2367423C2 (ru) 2003-12-19 2009-09-20 ОМЕГА БИО-ФАРМА (Ай.Пи. 3) ЛИМИТЕД Композиции и способы для лечения диабета
EP1559419A1 (fr) * 2004-01-23 2005-08-03 Fournier Laboratories Ireland Limited Composition pharmaceutique contenant une combinaison de mefformine et d'un fibrate et les procédés pour les obtenir
WO2005074909A1 (fr) * 2004-02-09 2005-08-18 Aska Pharmaceutical Co., Ltd. Medicament de combinaison
EP1591114A1 (fr) * 2004-03-12 2005-11-02 Fournier Laboratories Ireland Limited Utilisation de la metformine et de l'Orlistat pour le traitement ou la prévention de l'obésité
US20060286182A1 (en) * 2005-06-21 2006-12-21 Abeille Pharmaceuticals, Inc. Synergistic cinnamon combinations and methods for enhancing insulin activity
GB0602639D0 (en) * 2006-02-09 2006-03-22 Novartis Ag Organic compounds
WO2008015763A1 (fr) 2006-08-04 2008-02-07 Aska Pharmaceutical Co., Ltd. Formulation médicamenteuse contenant un médicament fibrate et procédé pour la produire
CN101342164B (zh) * 2007-08-21 2011-04-20 阜新市仙鹤制药有限责任公司 苯扎贝特控释制剂及其制备方法
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9339458B2 (en) * 2009-02-18 2016-05-17 Itf Research Pharma, S.L.U. Use of vaginal insulin sensitizing agents
ES2344183B1 (es) * 2009-02-18 2011-06-10 Italfarmaco, S.A. Uso de agentes sensibilizantes a insulina por via vaginal.
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
JP2012171911A (ja) 2011-02-22 2012-09-10 Kao Corp Ｐｐａｒ活性化剤
US9382187B2 (en) * 2012-07-10 2016-07-05 Thetis Pharmaceuticals Llc Tri-salt form of metformin
US8765811B2 (en) * 2012-07-10 2014-07-01 Thetis Pharmaceuticals Llc Tri-salt form of metformin
MX2015000408A (es) * 2012-07-10 2015-07-14 Thetis Pharmaceuticals Llc Forma de triple sal de metformina.
EP3140316A1 (fr) 2014-05-05 2017-03-15 Thetis Pharmaceuticals LLC Compositions et procédés se rapportant à des sels ioniques de peptides
WO2015183794A1 (fr) 2014-05-27 2015-12-03 City Of Hope Complexes d'agonistes de tgr5 pour le traitement du diabète et du cancer
EP3157936B1 (fr) 2014-06-18 2018-10-17 Thetis Pharmaceuticals LLC Complexes d'acides aminés minéraux d'agents actifs
US9242008B2 (en) 2014-06-18 2016-01-26 Thetis Pharmaceuticals Llc Mineral amino-acid complexes of fatty acids
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Esters de (17-β)-hydroxy-4-androstène-3-one biodisponibles à l'état solide
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
FR3050112B1 (fr) * 2016-04-15 2020-09-04 Soc Civ Immobiliere Gecinq Utilisation de l'acide fenofibrique dans le traitement des maladies hepatiques
JP6906047B2 (ja) 2016-06-03 2021-07-21 テティス・ファーマシューティカルズ・エルエルシー 特異的炎症収束性メディエーターの塩に関連する組成物及び方法
WO2018058109A1 (fr) * 2016-09-26 2018-03-29 Nusirt Sciences, Inc. Compositions et méthodes pour le traitement de troubles métaboliques
FR3056908B1 (fr) * 2016-09-30 2019-04-19 Nashpharm Sel de metformine et d'elafibranor presentant une activite duale pour le traitement de l'obesite associee a la steato-hepatite non alcoolique (nash) et a l'hypertriglyceridemie
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
AU2019308326B2 (en) 2018-07-20 2025-07-31 Lipocine Inc. Liver disease
GB2599950A (en) * 2020-10-16 2022-04-20 Zentiva Ks Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same
WO2023119100A1 (fr) * 2021-12-22 2023-06-29 Mankind Pharma Ltd. Compositions pharmaceutiques stables

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2264525B1 (fr) * 1974-03-22 1977-11-04 Expl Marques Brevets Et
US4080472A (en) 1974-03-22 1978-03-21 Societe D'etudes Et D'exploitation De Marques Et Brevets S.E.M.S. Metformin 2-(p-chlorophenoxy)-2-methylpropionate
DE3729209A1 (de) 1987-09-01 1989-03-09 Boehringer Mannheim Gmbh Verwendung von bezafibrat zur behandlung von diabetes
ZA918168B (en) * 1990-10-16 1993-04-14 Takeda Chemical Industries Ltd Prolonged release preparation and polymers thereof.
JP3852621B2 (ja) * 1992-01-21 2006-12-06 あすか製薬株式会社 血管内皮細胞機能改善剤
WO1998005331A2 (fr) * 1996-08-02 1998-02-12 Ligand Pharmaceuticals Incorporated Prevention ou traitement de diabetes non insulinodependants ou de maladies cardiovasculaires avec des modulateurs ppar

Also Published As

Publication number Publication date
EP1054665A2 (fr) 2000-11-29
KR100567608B1 (ko) 2006-04-04
ATE204754T1 (de) 2001-09-15
PT1054665E (pt) 2002-02-28
BRPI9907866B1 (pt) 2017-08-15
NO20004056D0 (no) 2000-08-11
CA2320039A1 (fr) 1999-08-19
DE69900249D1 (de) 2001-10-04
HUP0100801A3 (en) 2001-12-28
JP2002502869A (ja) 2002-01-29
ES2162517T3 (es) 2001-12-16
FR2774591B1 (fr) 2000-05-05
HU224619B1 (hu) 2005-11-28
HUP0100801A2 (hu) 2001-08-28
RU2207850C2 (ru) 2003-07-10
AU2923399A (en) 1999-08-30
NO328314B1 (no) 2010-01-25
CN1151785C (zh) 2004-06-02
HK1034913A1 (en) 2001-11-09
KR20010040925A (ko) 2001-05-15
WO1999040904A2 (fr) 1999-08-19
AU746821B2 (en) 2002-05-02
ZA991077B (en) 1999-08-11
CZ20002828A3 (cs) 2000-11-15
PL342665A1 (en) 2001-07-02
CA2320039C (fr) 2008-07-22
EP1054665B1 (fr) 2001-08-29
ID26254A (id) 2000-12-07
PL196874B1 (pl) 2008-02-29
AR018286A1 (es) 2001-11-14
MY118164A (en) 2004-09-30
SK283212B6 (sk) 2003-03-04
FR2774591A1 (fr) 1999-08-13
NO20004056L (no) 2000-08-11
TW518222B (en) 2003-01-21
SK11562000A3 (sk) 2000-12-11
BR9907866A (pt) 2000-10-31
CZ290101B6 (cs) 2002-05-15
US6372790B1 (en) 2002-04-16
JP4767411B2 (ja) 2011-09-07
BRPI9907866B8 (pt) 2021-05-25
WO1999040904A3 (fr) 1999-09-30
UA70315C2 (en) 2004-10-15
DE69900249T2 (de) 2002-06-13
CN1290160A (zh) 2001-04-04

Similar Documents

Publication Publication Date Title
DK1054665T3 (da) Farmaceutisk præparat omfattende en kombination af metformin og fibrat og anvendelse deraf til fremstilling af medikamenter beregnet til at reducere hyperglykæmi
HUP0300642A3 (en) Pharmaceutical composition comprising a combination of metformin and another antidiabetic agent
IL163278A (en) Formulations including glp-1 compounds and their use in drug preparation
NO20012245L (no) Anthranilsyreamider og anvendelse derav som medikamenter
EE200000232A (et) Farmatseutiline kompositsioon ja selle kasutamine
DK589086A (da) Farmaceutisk sustained release praeparat indeholdende dextromethorphansamt dets fremstilling og anvendelse
IL155196A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
NO20005913L (no) Legemiddelsammensetning
IL149139A0 (en) Pharmaceutical compositions containing metformin and glyburide
HUP0101293A3 (en) Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use
DK40398A (da) Præparat og anvendelse deraf ved fremstilling af et lægemiddel til lindring af Dupuytren's syndrom
DK0934057T3 (da) Medicinske aerosolformuleringer med formoterol
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
IL150383A0 (en) Glyburide and pharmaceutical compositions containing the same
HUP0400988A3 (en) Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments
IL153513A (en) Pharmaceutical preparation containing a combination of sulfonylurea as an antidiabetic agent and fbpase inhibitor and their use in the preparation of drugs for the treatment of diabetes
ITMI931325A0 (it) Composizione farmaceutica ad attivita' analgesica
BR9907100B1 (pt) pentassacarídeos, composição farmacêutica compreendendo os mesmos e utilização dos ditos pentassacarídeos
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
IT1286496B1 (it) Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
EP1124557A4 (fr) Composition pharmaceutique
DE69725166D1 (de) Substituierte benzamidderivate und diese enthaltende pharmazeutische zusammensetzung
EE200300138A (et) Epinastiini ja pseudoefedriini sisaldavad farmatseutilised kompositsioonid
FI935170A7 (fi) Uudet kiraalit sulfaatit, niiden valmistus ja käyttö farmaseuttisten y hdisteiden synteesissä
SI1054665T1 (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the treatment of hyperglycemia